Pfizer in Rhythm

Impressed with Rhythm Pharmaceuticals Inc.'s progress on an obesity target that has eluded big pharma's small molecule approaches for 15 years, Pfizer Inc. (NYSE:PFE) decided to make a strategic investment in the biotech.